Cyagen Closes on ￥285M Series B Round

According to VCBeat, Cyagen Biosciences ("Cyagen") has completed its ￥285M series B financing, with participation from four well-known investment companies including China Merchants Securities Zhiyuan Capital, GF Qianhe Investment, GF Xinde Investment and Grower Venture Capital.

Proceeds of this fund will be used to expand the business at home and abroad, build facilities of more than 4 square meters in central China, north China, south China and southwest China, strongly promote its strategy in North America, Europe and the Asia-Pacific region and cooperate further with leading companies in the European and American area for globalization.

Cyagen is a 400-employee company headquartered in Santa Clara, California, with additional locations in Japan and China, and production facilities in China. It is one of the largest providers of custom-engineered mouse and rat models globally. Cyagen's services have become well known for the top quality, full guarantee, and competitive prices. Additionally, Cyagen offers a comprehensive series of stem cell products for research use, including cell lines, media, and differentiation kits.

Cyagen is committed to combining technologies like gene editing, biological big data with animal models, and providing the most economical and accurate in vivo model for life science research, clinical treatment research, and drug development and screening. Cyagen provides more than 4000 cases of custom genetically modified rodent models every year for thousands of life science and clinical research institutions, CRO, pharmaceutical companies and biotechnology companies all over the world.

CMSC is a venture capital and private equity firm as a wholly-owned subsidiary of China Merchants Securities Co., Ltd. ("CMS"). With rich customer resources, industrial resources, with a professional investment team, CMSC provides multi-level financial services for all participants in the capital market.

GF Qianhe Investment is a wholly-owned investment subsidiary of GF Securities Co., Ltd. The company is currently engaged in the equity investment business, aiming at creating market influence and differentiated competitive advantages in the PE market, and expanding stable investment channels that can absorb large amounts of capital in other new fields, striving to become the industry's leading alternative investment platform.